Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04795713
Title Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Molecular Templates, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Medical Center Duarte California 91010 United States Details
USC Medical Center Los Angeles California 90033 United States Details
Cedars Sinai Medical Center Los Angeles California 90048 United States Details
Comprehensive Care and Research Center - Atlanta Newnan Georgia 30265 United States Details
Comprehensive Care and Research Center - Chicago Chicago Illinois 60099 United States Details
University of Louisville Health - Brown Cancer Center Louisville Kentucky 40202 United States Details
Washington University School of Medicine - St. Louis Saint Louis Missouri 63110 United States Details
Dartmouth Hitchcock Lebanon New Hampshire 03766 United States Details
Carolina BioOncology Huntersville North Carolina 28078 United States Details
Pennsylvania Cancer Specialists and Research Institute Gettysburg Pennsylvania 17325 United States Details
Prisma Health Greenville South Carolina 29605 United States Details
Sanford Cancer Center Sioux Falls South Dakota 57104 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
Oncology Consultants Houston Texas 77024 United States Details
South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field